OS Therapies files prospectus for resale of up to 5,874,094 shares by selling stockholders
OSTX•Prospectus supplement filed for resale shares
- OS Therapies filed a prospectus supplement for the resale of up to 5,874,094 common shares by selling stockholders.
- The filing forms part of an existing shelf registration statement on Form S-3.
